INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $831,000 | -56.3% | 59,552 | -56.7% | 0.13% | -25.0% |
| Q2 2022 | $1,900,000 | -13.0% | 137,596 | +2.5% | 0.17% | -10.6% |
| Q1 2022 | $2,183,000 | +443.0% | 134,182 | +444.2% | 0.19% | +506.5% |
| Q4 2021 | $402,000 | -82.4% | 24,657 | -78.5% | 0.03% | -79.5% |
| Q2 2021 | $2,287,000 | -10.4% | 114,515 | +3.5% | 0.15% | -17.5% |
| Q1 2021 | $2,552,000 | -1.2% | 110,592 | +5.7% | 0.18% | +4.6% |
| Q4 2020 | $2,584,000 | -40.6% | 104,604 | -0.2% | 0.18% | -39.0% |
| Q3 2020 | $4,347,000 | -36.2% | 104,846 | +94.4% | 0.29% | +1.4% |
| Q3 2018 | $6,815,000 | +193.5% | 53,932 | +94.9% | 0.28% | +221.6% |
| Q2 2018 | $2,322,000 | -57.4% | 27,672 | +20.3% | 0.09% | -38.0% |
| Q3 2014 | $5,446,000 | – | 23,011 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |